(Q44709582)

5 December 2017

Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. (English)

1 reference

5 December 2017

1 reference

J Bestman-Smith

1

1 reference

5 December 2017

P Gourde

2

1 reference

5 December 2017

A Désormeaux

3

1 reference

5 December 2017

M J Tremblay

4

1 reference

5 December 2017

M G Bergeron

5

1 reference

5 December 2017

1 September 2000

1 reference

Biochimica et Biophysica Acta

5 December 2017

1 reference

5 December 2017

1468

1 reference

5 December 2017

1-2

1 reference

5 December 2017

161-174

1 reference

Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Human immunodeficiency virus. Trapped but still dangerous

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

How to prolong the effects of combination therapy for HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Trials and tribulations: ethical dilemmas in HIV therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Antiretroviral therapy for HIV infection: promises and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

New developments in the biology and treatment of HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

HIV survives drug onslaught by hiding out in T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution, and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Long-circulating (sterically stabilized) liposomes for targeted drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2800%2900254-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2736(00)00254-6

1 reference

5 December 2017

1 reference